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Abstract
Purpose:  The  aim  of  this  study  was  to  compare  the  effects  of  pulmonary  rehabilitation  (PR)  on
six-minute  walk  test  (6mWT)  between  chronic  obstructive  pulmonary  disease  (COPD)  patients
with moderate  or  severe  carbon  monoxide  diffusion  defects.  We  also  evaluated  dyspnea  sen-
sation, pulmonary  functions,  blood  gases  analysis,  quality  of  life  parameters  and  psychological
symptoms  in  both  groups  before  and  after  pulmonary  rehabilitation.
Methods:  Patients  with  COPD  underwent  a  comprehensive  8-week  out-patient  PR  program  par-
ticipated in  this  study.  Patients  grouped  according  to  diffusion  capacity  as  moderate  or  severe.
Outcome measures  were  exercise  capacity  (6mWT),  dyspnea  sensation,  pulmonary  function
tests, blood  gases  analysis,  quality  of  life  (QoL)  and  psychological  symptoms.
Results:  A  total  of  68  patients  enrolled  in  the  study.  Thirty-two  (47%)  of  them  had  moderate
diffusion defect  [TlCO;  52  (47--61)  mmol/kPa]  and  36  (53%)  of  them  had  severe  diffusion  defect
[TlCO;  29  (22--34)  mmol/kPa].  At  the  end  of  the  program,  PaO2 (p  =  0.001),  Modiﬁed  Medical
Research Council  dyspnea  scale  (p  =  0.001),  6mWT  (p  <  0.001)  and  quality  of  life  parameters
improved  signiﬁcantly  in  both  groups  (p  <  0.05).  Also  the  improvement  in  DlCO (p  =  0.04)  value
and FEV1%  (p  =  0.01)  reached  a  statistically  signiﬁcant  level  in  patients  with  severe  diffusion
defect. When  comparing  changes  between  groups,  dyspnea  reduced  signiﬁcantly  in  patients
with severe  diffusion  defect  (p  =  0.04).∗ Corresponding author.
E-mail address: yeldavatansever@hotmail.com (Y. Varol).
http://dx.doi.org/10.1016/j.rppnen.2016.03.003
2173-5115/© 2016 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusion:  Pulmonary  rehabilitation  improves  oxygenation,  severity  of  dyspnea,  exercise
capacity and  quality  of  life  independent  of  level  of  carbon  monoxide  diffusion  capacity  in
patents with  COPD.  Furthermore  pulmonary  rehabilitation  may  improve  DlCO values  in  COPD
patients with  severe  diffusion  defect.
© 2016  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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untroduction
hronic  obstructive  pulmonary  disease  (COPD)  is  deﬁned
y  airﬂow  limitation  and  is  a  complex  pathological  condi-
ion.  COPD  is  associated  with  an  important  reduction  in
hysical  activity  that  contributes  to  the  patient’s  disability
nd  poor  health-related  quality  of  life.  Pulmonary  reha-
ilitation  (PR)  is  aimed  to  eliminate  or  at  least  attenuate
hese  difﬁculties.1,2 Therefore,  PR  has  been  recommended
s  an  integral  part  of  management  for  patients  with  COPD.3,4
owever,  the  responses  to  PR  may  vary  signiﬁcantly  among
ndividuals.  Although  there  are  many  studies  mentioning
hanges  of  FEV1,  FVC,  FEV1/FVC  after  PR,  in  some  studies,
igniﬁcant  changes  in  forced  expiratory  volume  in  one  sec-
nd  (FEV1),  forced  vital  capacity  (FVC)  and  FEV1/FVC  values
ere  not  detected  after  PR.5--8
The  diffusing  capacity  for  carbon  monoxide  (DlCO)  is  a
ommon  and  clinically  useful  test  that  provides  a  quanti-
ative  measure  of  gas  transfer  in  the  lungs.9 The  decrease
n  DlCO,  one  of  the  ﬁrst  signs  of  disease  progression,  can
oint  out  the  arterial  O2 desaturation  during  exercise.  For
OPD  patients  with  low  DlCO values  pose  a  high  risk  for  poor
urvival.10 Although  PR  is  known  to  have  many  effects  on
unctional  outcomes  of  COPD  patients,  there  is  not  enough
nformation  about  the  diffusion  capacity  in  terms  of  PR
utcome.2 Also  in  a  recent  study  authors  suggest  that  diffus-
ng  capacity  was  the  strongest  predictor  of  exercise  capacity
n  all  subjects  with  COPD.11 Therefore  can  CO  diffusion
apacity  be  used  to  evaluate  which  patient  will  beneﬁt  more
rom  PR  program?  Moreover  will  there  be  a  signiﬁcant  change
n  CO  diffusion  capacity  after  PR  program  in  patients  with
OPD?
The  aim  of  our  study  was  to  compare  the  results  of  PR  pro-
ram  on  exercise  capacity  (6mWT)  between  COPD  patients
ith  moderate  and  severe  diffusion  defect  detected  by
lCO.  Our  secondary  aims  were  comparing  the  results  of  the
rogram  on  arterial  blood  gas  analysis,  dyspnea  sensation,
xercise  capacity,  quality  of  life  and  psychological  symptoms
etween  two  groups.
ethods
e  conducted  a  prospective  cohort  study  to  compare  the
ffectiveness  of  exercise  training  in  COPD  patients  with
oderate  and  severe  diffusion  defect.  The  study  was
pproved  by  the  local  institutional  review  board.  Patients
ncluded  in  the  study  completed  an  informed  written  con-
ent  form.
g
a
l
cubject  selection
e  recruited  COPD  patients  diagnosed  according  to  Global
nitiative  for  Chronic  Obstructive  Lung  Disease  (GOLD)  def-
nition,  stable  from  exacerbations  (with  no  worsening  of
espiratory  symptoms,  no  increase  in  the  use  of  rescue
edication,  and  no  unscheduled  visits  due  to  COPD  wors-
ning)  for  at  least  4  weeks.  All  patients  were  suffering
rom  dyspnea,  reduced  exercise  tolerance  and  limitation  of
aily  living  activities.  The  recruitment  criteria  included  a
inimum  age  of  40  years  old,  a  history  of  10  or  more  pack-
ears  of  smoking,  a  FEV1  of  less  than  80%  of  the  predicted
alue  after  bronchodilator  use  and  a  ratio  of  FEV1  to  FVC
f  0.7  or  less  after  bronchodilator  use.12 The  condition  of
he  patients  was  graded  according  to  the  stages  of  disease
eﬁned  by  the  GOLD.13 The  patients’  self-reported  respira-
ory  symptoms,  medications,  smoking  history,  and  coexisting
edical  conditions  were  documented  at  the  beginning  of
he  study.  Comorbid  diagnoses  were  established  using  the
linical  history  and  physical  examination  ﬁndings  during  the
isit  and  were  supported  by  a  review  of  the  available  medi-
al  records.  We  excluded  patients  who  were  suffering  from
cute  exacerbation,  history  of  other  lung  diseases,  (pneumo-
oniosis,  pulmonary  tuberculosis,  interstitial  lung  disease);
nd  orthopedic,  neurologic,  or  cardiovascular  impairment
hat  might  render  the  subject  incapable  of  completing  the
xercise  training.  Also  subjects  with  lack  of  motivation,  poor
ompliance  (not  attending  the  program  more  than  2  times)
r  having  transport  problems  were  excluded  from  the  study.
e  grouped  patients;  those  with  diffusion  capacity  between
1  and  60%  of  predicted  as  moderate  (group  1)  and  under  40%
f  predicted  as  severe  (group  2)  diffusion  defect.14
easurement  of  pulmonary  parameters  and
uestionnaires
ll  patients  underwent  cardiac  and  respiratory  system  exam-
nations  and  were  evaluated  by  chest  X-rays  and  blood  gases
nalysis.  Pulmonary  functions  were  assessed  by  measur-
ng  body  plethysmography  (Zan  500,  Germany)  and  carbon
onoxide  diffusing  capacity  test  (Zan  300,  Germany).  The
LCO  maneuver  begins  with  a  full  exhalation  to  residual  vol-
me  (RV),  the  mouthpiece  is  then  connected  to  the  test
as  (0.3  percent  carbon  monoxide  [CO],  10  percent  helium),
nd  the  subject  inhales  rapidly  to  total  lung  capacity.  Fol-
owing  a  10  s  breath  hold,  the  subject  exhales  quickly  and
ompletely  to  RV.  An  alveolar  sample  of  the  exhaled  gas
onary  rehabilitation  325
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Fig.  1  Exercise  capacity  (6  minute  walk  test)  of  the  patients
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DSevere  diffusing  capacity  predict  a  better  outcome  for  pulm
is  then  analyzed  for  calculation  of  the  dilution  of  helium
and  the  uptake  of  CO.  Dyspnea  was  assessed  by  Modi-
ﬁed  Medical  Research  Council  (MMRC)  dyspnea  scale  and
modiﬁed  BORG  scales.3 Quality  of  life  was  assessed  using
disease  speciﬁc  St.  George  Respiratory  Questionnaire  and
SF-36  health  related  quality  of  life  questionnaire.15,16 Psy-
chological  symptoms  were  assessed  by  Hospital  Anxiety  and
Depression  Questionnaires.17,18 6-Minute  walking  test  was
used  which  was  deﬁned  by  American  Thoracic  Society  (ATS)
standards.19 All  measurements  were  assessed  at  admission
and  at  the  end  of  the  PR.
Pulmonary  rehabilitation  parameters
Patients  underwent  an  8-week  hospital  based  out-patient
pulmonary  rehabilitation  program  twice  a  week  in  our
hospital’s  Pulmonary  Rehabilitation  Unit.  Pulmonary  reha-
bilitation  was  completely  tailored  to  suit  the  needs  of  the
individual.  PR  program  consists  of  education,  supervised
exercise  training,  nutritional  intervention  and  psychological
counseling,  if  needed.  Exercises  were  chosen  for  each
patient  for  their  ability  to  tolerate  exercise  and  their
disease  severity.  Exercises  included;  breathing  exercises,
treadmill  (at  least  15  minutes)  and  cycle  training  (at  least
15  minutes),  peripheral  muscle  training,  and  stretching
exercises.  Also  we  informed  patients  about  medication
advices,  bronchial  hygiene  techniques,  energy  conserva-
tion,  relaxation  techniques  for  reducing  dyspnea  and  home
exercises.3 After  respiratory  physiotherapy  education,
upper  and  lower  extremity  stretching  and  strengthening
exercises  were  performed.  All  strengthening  exercises  were
started  without  a  weight.  During  PR  program  according
to  the  BORG  scale4--6 half  a  kilogram  weight  is  added  in
every  4  periods  of  exercises.  The  treadmill  and  bicycle/arm
ergometer  were  used  for  aerobic  exercises.  We  calculated
both  workloads  for  cycling  and  walking  speed  for  treadmill
from  six  minutes’  walk  test.4 Treadmill  walking  speed  is
calculated  by  80%  of  average  6MWT  speed  using  formula:
(6mWT  distance  ×  10)/1000  km/h.  Cycling  workload  was
calculated  with  the  formula  (Watt  =  103.217  +  (30.500  ×
Sex)  +  (−1.613  ×  age)  +  [(0.002  ×  distance  ×  weight)]  sex;
male  =  1  female  =  0).  Patients  were  trained  at  60--90%  of
maximum  heart  rate.  Also  we  used  BORG  dyspnea  scores
for  regulation  of  exercise.3--20 Exercise  intensity  increased
according  to  the  patient  progress.  During  exercise  we  used
pulse  oximetry  to  supervise  patients  and  if  the  SpO2 fell
below  90%  oxygen  supplementation  was  provided.
Statistical  analysis
We  performed  statistical  analyses  using  the  SPSS  17.0  (Sta-
tistical  Package  for  the  Social  Sciences,  Chicago,  Illinois).
Descriptive  statistics  were  performed  for  all  the  recorded
variables.  The  normality  of  the  data  was  evaluated  by  Kol-
mogorov  Smirnow  test.  We  used  Mann  Whitney-U  test  to
compare  baseline  characteristics  and  changing  outcomes  as
shown    values  before  and  after  PR.  We  used  Wilcoxon  test
to  compare  variables  between  before  and  after  PR.  p <  0.05
value  is  considered  as  signiﬁcant.
W
a
wefore  and  after  pulmonary  rehabilitation  (p  <  0.05  for  within
roup  change,  p  =  0.16  between  groups).
esults
emographic  data
 total  of  68  patients  (61  men  %90)  participated  in  this  study.
hirty-two  (47%)  patients  had  moderate  diffusion  defect
TlCO;  57  (47--61)  mmol/kPa]  (group  1)  and  36  (53%)  patients
ad  severe  diffusion  defect  [TlCO;  29  (22--34)  mmol/kPa]
group  2).  All  patients  had  smoking  history.  Groups  were
imilar  in  terms  of  age,  gender  and  cigarette  consumption
p  >  0.05).  Body  mass  index  (BMI)  was  signiﬁcantly  lower  in
atients  with  severe  diffusion  defect  (p  <  0.05).
nitial  measurements  before  PR
hen  comparing  initial  measurements;  exercise  capacity,
uality  of  life,  FEV1,  FEV1/FVC,  PaO2,  SaO2 were  signiﬁ-
antly  lower  in  group  2  (p  <  0.05)  before  PR  in  comparison
ith  group  1  (Table  1).  Also  dyspnea  sensation  and  anxiety
evels  were  signiﬁcantly  higher  in  group  2  compared  with
roup  1  before  PR.
nitial  measurements  after  PR
fter  PR  program  there  was  a  statistically  signiﬁcant
ncrease  in  6mWT  in  both  groups  (401--443  m  for  group
,  328--388  m  for  group  2,  p  <  0.001,  both)  (Fig.  1).  In
oth  groups  PaO2 signiﬁcantly  increased  after  rehabilitation
p  <  0.05,  both).  After  rehabilitation,  signiﬁcant  improve-
ent  recorded  in  dyspnea  sensation  (mMRC  scores)  and
GRQ  scores  (−9  for  group  1,  −7  for  group  2)  in  both
roups  (p  <  0.05)  (Table  2).  There  was  no  signiﬁcant  dif-
erence  in  both  groups  in  term  of  FEV1/FVC,  IC,  VC,
pH,  PaCO2,  Role  emotional  scores  (SF-36)  and  mental
ealth  score  (SF-36)  after  PR  program.
ifferences  between  groups  1  and  2hen  comparing  changes  between  groups;  in  group  1  the
verage  change  in  6mWT  was  40  (min  21,  max  50)  meters,
hile  in  group  2  the  change  was  50  (min  30,  max  70)  meters
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Table  1  Baseline  demographic  and  clinical  features  of  patients.
Variable  Group  1  (n  =  32)  Group  2  (n  =  36)  p
Age  (years) 60  (55,  66) 63  (57,  67)  0.168
BMI (kg/m2)  28  (26,  31)  23  (20,  28)  0.001
Male gender  n  (%)  30  (93.8)  31  (86.1)  0.434
Smoking (p/years)  50  (33,  70)  50  (47,  80)  0.308
FEV1 (%  predicted)  48  (37,  63)  34  (25,  50)  0.003
FEV1/FVC 64  (54,  72)  51  (41,  65)  0.000
IC (%  predicted)  69  (41,  86)  47  (37,  65)  0.052
VC (%  predicted)  70  (56,  77)  58  (46,  79)  0.212
DLCO 57  (47--61) 29  (22--34) 0.000
pH 7.41  (7.39,  7.43) 7.40  (7.38,  7.43) 0.912
PaO2 72  (67,  83) 68  (58,  75) 0.020
PaCO2 39  (38,  43)  42  (36,  47)  0.483
SaO2 95  (93,  96)  93  (90,  95)  0.009
6MWD (meters)  414  (352,  464)  340  (300,  380)  0.001
BORG 1  (0.5,  2)  2  (1,  3)  0.014
MMRC 3  (2,  3)  4  (3,  4)  0.000
HADa 5.5  (3,  8)  9  (6,  14)  0.002
HADd 5  (3,  9)  7.5  (5,  11)  0.095
SGRQ
Symptom 48  (30,  58)  67  (51,  79)  0.000
Activity 55  (42,  67)  73  (59,  92)  0.000
Impact 40  (27,  46)  49  (35,  69)  0.005
Total 46  (31,  55)  60  (46,  72)  0.000
SF36
Physical functioning  (PF)  60  (40,  85)  45  (20,  65)  0.023
Social functioning  (SF)  87  (62,  100)  62  (25,  75)  0.004
Role physical  (RF)  25  (0,  100)  0  (0,  50)  0.151
Role emotional  (RE)  66  (0,  100)  33  (0,  100)  0.091
General health  (GH)  52  (30,  67)  35  (20,  52)  0.024
Mental health  (MH) 76  (64,  88)  64  (50,  76)  0.066
Bodily pain  (BP) 74  (42,  100) 52  (32,  88)  0.038
Vitality (VT) 55  (45,  80)  50  (29,  60)  0.020
Data are expressed as median (interquartile range) or %, BMI: body mass index, FEV1: forced expiratory volume in the 1 s, FVC: forced vital
capacity, IC: inspiratory capacity, VC: vital capacity, PaCO2: partial arterial carbon dioxide pressure. SaO2: arterial oxygen saturation,
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t6MWD: six minutes walk distance, MMRC: Medical Research Counc
St. George Respiratory Questionnaire, SF-36: Short-Form Health S
Table  2).  There  was  no  signiﬁcant  difference  between
roups  in  terms  of  6mWT  change.  The  changes  in  PaO2 lev-
ls  were  signiﬁcantly  higher  in  group  2,  compared  to  group
 (Table  2).  Improvement  of  dyspnea  sensation  was  sig-
iﬁcantly  higher  in  patients  with  severe  diffusion  defect
ompared  to  group  1  (p  =  0.04)  (Table  2).  There  was  no
ifference  in  SGRQ  scores,  SF-36  and  HAD  scores  between
roups  1  and  2  comparing  changes  in  QoL  parameters
p  > 0.05)  (Table  2).  In  addition;  FEV1%  and  DlCO increased
n  patients  with  only  severe  diffusion  defect  (p  <  0.05)
Table  2).
iscussion
n  this  study  we  found  signiﬁcant  improvement  in  oxygen-
tion  (PaO2),  severity  of  dyspnea,  exercise  capacity  and
uality  of  life  parameters  in  patents  with  moderate  and
evere  diffusion  defect  after  PR  program.  Additionally  FEV1
nd  DlCO increased  signiﬁcantly  in  patients  with  severe  dif-
usion  defect.  When  comparing  changes  between  groups;
m
t
sspnea Scale, HAD: Hospital Anxiety and Depression Scale, SGRQ:
.
mprovement  in  dyspnea  sensation  was  signiﬁcantly  higher
n  patients  with  severe  diffusion  defect.
All  studies  about  effects  of  pulmonary  rehabilitation  on
ung  function  have  investigated  FEV1,  FVC,  FEV1/FVC  and
lood  gas  analysis.  There  are  few  studies  conducted  on
nvestigating  the  effect  of  PR  program  on  different  DlCO
roups.21,22 COPD  is  characterized  by  high  morbidity  and
ortality.  It  remains  unknown  which  aspect  of  lung  function
arries  the  most  prognostic  information.  In  a study  of  604
OPD  patients  which  were  clinically  stable  it  was  concluded
hat  DlCO was  the  most  powerful  predictor  of  survival.23 In
nother  study  in  patients  with  COPD  it  was  emphasized  that
EV1,  IC  and  DlCO were  higher  predictive  regarding  exercise
apacity  and  DlCO was  the  strongest  predictor.11 In  a  5-year
ollow  up  study  it  was  found  that  decline  in  12-minute  walk
est  was  mainly  explained  by  deterioration  in  DlCO and  this
easurements  at  baseline  were  the  most  important  predic-
ors  of  declining  exercise  capacity  in  COPD  patients.24
Single  measurements  of  DlCO in  patients  with  COPD  have
hown  that  a  reduced  value  in  early  disease  is  associated
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Table  2  Comparison  of  changes  in  exercise  capacity,  dyspnea,  pulmonary  functions,  blood  gas  analyses,  quality  of  life  and
psychological  symptoms  between  two  groups.
Outcomes  Group  1  (n  =  32)  Group  2  (n  =  36)  p
6MWTD  (meter)  40  (21,  50)* 50  (30,  70)* 0.160
BORG −0.05  (−1.0)  −0.05  (−1.5,  0)* 0.587
MMRC 0  (−1.0)* −1  (−1.0)* 0.044
FEV1 (%  predicted)  1.5  (−2.7,  6.5)  3  (−1,  6.8)* 0.413
FEV1/FVC 0  (−8.7,  3.7)  −0.5  (−5,  9.5)  0.214
IC (%  predicted)  2  (−16.5,  15)  2  (−9,  30)  0.513
VC (%  predicted)  5  (−4.5,  11.5)  3  (−9,  18)  0.212
DLCO (%  predicted) −1 (−7,  7.5) 7.5  (−4,  13)* 0.019
pH 0.001  (−0.01,  0.02) 0.005  (−0.02,  0.03) 0.965
PaO2 (mmHg) 4  (1,  9)* 7.5  (3,  11)* 0.035*
PaCO2 (mmHg)  0  (−4.5,  4.7)  −0.5  (−5.5,  1)  0.235
SaO2 1  (0,  2)* 1  (0,  3)* 0.656
SGRQ
Symptom  −7  (−15,  5)  −8  (−15,  1)* 0.495
Activity −7  (−18,  −0.03)* −6  (−18,  0.2)* 0.901
Impact −8  (−18,  −3)* −7  (−17,  0.8)* 0.636
Total −9  (−15,  −2)* −7  (−15,  −3)* 0.953
SF-36
Physical functioning  (PF)  5  (−10,  30)* 5  (0,  21)* 0.979
Social functioning  (SF)  0  (0,  25)  12  (0,  25)* 0.401
Role physical  (RF)  5  (−10,  30)* 0  (0,  50)* 0.946
Role emotional  (RE)  0  (0,  33)  0  (0,  66)  0.586
General health  (GH)  7.5  (−4,  16)* 5  (−5,  17)* 0.746
Mental health  (MH)  0  (−8,  8)  2  (−9,  16)  0.838
Bodily pain  (BP)  0  (−10,  20)  5  (0,  34)* 0.293
Vitality (VT)  5  (−5,  25)  10  (0,  25)* 0.424
HADanxiety −1.5  (−4,  0.2)  −3  (−5,  −1)* 0.069
HADdepression 0  (−3,  2.2)  −2  (−5,  0.2)* 0.075
Data are expressed as median (interquartile range), Results are shown as change between post-treatment and baseline levels ( values).
* p < 0.05 for within group change, 6MWD: six minutes walk distance, MMRC: Medical Research Council Dyspnea Scale, FEV1: forced
expiratory volume in the 1 s, FVC: forced vital capacity, IC: inspiratory capacity, VC: vital capacity, DLCO: carbon monoxide diffusing
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St. George Respiratory Questionnaire, SF-36: Short-Form Health S
with  accelerated  decline  in  FEV1  and  in  advanced  disease
it  predicts  exercise  capacity  and  mortality.  In  population
studies  a  reduced  DlCO predicts  all-cause  mortality  more
strongly  than  a  reduced  FEV1.  It  also  stated  that  repeated
measurements  of  CO  transfer  in  individuals  were  needed  to
increase  the  present  poor  knowledge  of  the  natural  history
of  the  contribution  of  alveolar  disease  to  the  progression
of  COPD.25 In  a  study  performed  in  heavy  smokers  lower
diffusing  capacity  was  found  to  be  directly  correlated  with
decline  FEV1/FVC  ratio  and  a  greater  progression  of  CT  --
quantiﬁed  emphysema.26 Mohsenifar  et  al.  demonstrated
that  patients  with  reduced  DlCO,  particularly  when  <20%
of  predicted,  were  more  likely  to  have  reduced  PaO2 at
rest  and  were  more  likely  to  require  supplemental  oxygen
with  low  levels  of  activity.  They  pointed  out  DlCO was  useful
in  evaluating  whether  supplemental  oxygen  is  required  for
exercise.27 In  our  study,  consistent  with  the  other  studies,
FEV1,  FEV1/FVC,  PaO2,  SaO2,  exercise  capacity  and  quality
of  life  scores  were  signiﬁcantly  lower  in  patients  with  severe
diffusion  defect  before  pulmonary  rehabilitation.
Pulmonary  rehabilitation  has  emerged  as  a  recommended
standard  of  care  for  patients  with  chronic  lung  disease.1,28 It
I
d
g
W carbondioxide pressure. SaO2: arterial oxygen saturation, SGRQ:
, HAD: Hospital Anxiety and Depression Scale.
as  been  demonstrated  to  improve  exercise  capacity,  reduce
ymptoms  of  dyspnea  and  increase  health-related  quality  of
ife.28,32 Pulmonary  function  tests  showed  different  results
fter  pulmonary  rehabilitation  in  previous  studies.  In  most
f  them,  signiﬁcant  changes  in  FEV1,  FVC  and  FEV1/FVC
alues5--8 were  not  detected.  Because  rehabilitation  is  a
ulticomponent  intervention  the  results  are  controversial.
n  a  study  of  24  patients  with  COPD  who  carried  out  at
east  half  an  hour  of  pranayama  breathing  exercises  for  3
onths,  despite  signiﬁcant  increase  in  PEF  values,  there
as  no  signiﬁcant  increase  in  FEV1  and  FVC.33 Cecily  et  al.
ad  observed  that  as  well  as  FEV1  and  FVC  the  value  of
EFR  (peak  expiratory  ﬂow  rate)  signiﬁcantly  had  increased
n  100  patients  with  COPD.34 Shebl  et  al.  concluded  that
EV1  increased  only  in  severe  COPD  but  FVC  and  FEV1/FVC
atio  was  increased  in  the  medium  and  severe  COPD  after
he  supervised  two-  month  home  based  exercise  program.
owever,  these  increases  were  not  statistically  signiﬁcant.35n  a  study  comparing  differences  of  improvement  by  gen-
er,  FEV1  and  FVC  increased  in  both;  however  they  were
reater  in  males  after  pulmonary  rehabilitation  program.36
hen  225  patients  were  assessed  according  to  severity  of
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OPD;  FEV1  increased  signiﬁcantly  in  stage  3  and  4,  VC  (vital
apacity)  increased  signiﬁcantly  to  2.3  and  4,  TLC  (total  lung
apacity)  decreased  signiﬁcantly  only  in  stage  3,  RV  (residual
olume)  were  signiﬁcantly  decreased  in  stage  3  and  4  after
ulmonary  rehabilitation  program.37 Unlike  other  studies,
fter  pulmonary  rehabilitation  for  3  years,  there  was  not  a
igniﬁcant  fall  in  FEV1  at  the  end  of  the  3rd  year.38
Changes  in  arterial  blood  gas  were  evaluated  less  and  the
esults  vary  in  previous  studies.  In  some  of  the  studies  PaO2,
aCO2 and  SaO2 did  not  change6,29 but  in  some  other  studies
oth  PaO2 and  SaO2 increased  signiﬁcantly  after  pulmonary
ehabilitation.21--39 A  study  that  assessed  blood  gas  analysis
ccording  to  severity  of  COPD  showed  that  PaO2 increased
igniﬁcantly  with  stage  3  and  4,  PaCO2 decreased  signiﬁ-
antly  in  stage  4  diseases  after  PR.37 There  are  few  studies
valuating  changes  in  diffusing  capacity  after  PR.  In  a  pre-
ious  study  conducted  in  our  clinic  there  was  a  signiﬁcant
ncrease  in  DlCO level  after  8  week  outpatient  rehabilitation
rogram  in  44  patients  with  COPD.21
Zanini  et  al.  divided  moderate  to  severe  COPD  patients
n:  75)  into  two  groups  depending  on  the  change  in  6MWT
responders  >30  m  and  no  responders  ≤30  m).  They  showed
hat  FEV1 <  50%  pred.  and  TLCO  <  50%  pred.  were  inde-
endent  predictors  of  PR  efﬁcacy.  They  also  found  that
omplex  COPD  patients  with  poor  lung  function  got  more
eneﬁt  from  PR.39 Sixty  patients  were  stratiﬁed  into  sub-
roups  according  to  airway  obstruction  (FEV(1)  >=  or  <50%
redicted),  pulmonary  hyperinﬂation  (TLC  >  or  <  or  =120%
redicted),  BMI  value  (BMI  > or  <  or  =25),  cardiovascular  (CV)
omorbidity,  and  resting  PaO(2)  (PaO(2)  >  =  or  <60  mmHg)
evels,  suggesting  that  subjects  with  poorer  exercise  capac-
ty  or  quality  of  life  had  greater  room  for  improvement.40
n  observational  study,  which  included  102  COPD  patients
ho  followed  PR  showed  that  patients  with  worse  disease
tatus  (i.e.  a  combination  of  lower  FEV1,  more  hyperinﬂa-
ion,  lower  exercise  capacity  and  worse  quadriceps  force)
mproved  most  in  endurance  exercise  capacity.41 Our  results
ere  similar  to  the  results  of  these  studies;  although  it  did
ot  reach  statistical  difference,  there  was  an  improvement
n  the  exercise  capacity  of  the  patients  with  severe  diffusion
efect  when  comparing  with  the  patients  having  moderate
iffusion  defect.  It  is  possible  that  the  improvement  in  6MWT
artially  reﬂects  the  gain  in  DLCO  and  lung  function  or  simply
eﬂects  the  fact  that  subjects  with  worse  COPD  have  more
oom  for  improvement  than  those  with  mild  COPD.  It  may
lso  indicate  that  emphysematous  COPD  subjects  have  a  bet-
er  chance  of  improvement  from  rehabilitation  than  chronic
ronchitis.  In  addition,  PaO2 and  O2 saturation  values  were
igniﬁcantly  increased  in  both  groups  with  a  little  difference
n  favor  of  the  patients  with  severe  diffusion  defect.  In  COPD
atients,  exercise  capacity  may  decrease  as  a  result  of  exer-
ise  intolerance,  ventilation  and  gas  exchange  impairment,
ardiac  failure  and  pulmonary  muscle  dysfunction  or  combi-
ation  of  them.  Hypoxia  due  to  gas  exchange  dysfunction
ay  directly  or  indirectly  decrease  exercise  tolerance.20
lCO which  is  a  good  predictor  of  gas  exchange  dysfunc-
ion  can  also  predict  exercise  restriction  perfectly.11 Older
extbooks  suggest  that  thickening  of  the  alveolar-capillary
embrane  (in  interstitial  lung  disease)  and  loss  of  alveo-
ar  membrane  surface  area  (in  emphysema)  are  the  primary
auses  of  a  low  DLCO.42 However,  new  experimental  data
uggest  that  diseases  that  inﬂuence  the  DLCO  do  so  by
C
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educing  the  volume  of  red  blood  cells  in  the  pulmonary
apillaries.43 In  healthy  adults  total  volume  of  blood  in  lungs
s  less  than  150  ml  at  rest.43 Diseases  which  reduce  alveolar-
apillary  surface  area  cause  a reduction  in  the  blood  volume
n  the  lungs.  The  blood  volume  in  the  pulmonary  capillaries
nd  the  DLCO  are  increased  during  exercise.42 Therefore,  we
ypotheses  that  the  increase  in  DLCO  after  PR  may  be  due
o  the  recruitment  of  pulmonary  capillaries  after  exercise.
Patients  with  severe  diffusion  defects  usually  avoid  exer-
ise  in  daily  life.  However,  PR  program  including  aerobic
nd  reinforcement  exercise  combination  may  improve  their
uscle  power,  exercise  performance  and  quality  of  life,  and
ay  give  them  the  courage  to  compete  with  their  dyspnea
ymptom.44 Improvement  in  DlCO and  FEV1  in  this  group
f  patients  may  reﬂect  the  success  in  muscle  exercise  as
 result  of  recruitment  of  pulmonary  capillaries.  Also  by
reathing  exercises  it  is  possible  that  the  exercise  may
everse  some  dead  space  ventilation,  and  make  new  areas
f  alveolar  more  available  to  gas  exchange.
Seventy-four  stable  COPD  patients  were  grouped  accord-
ng  to  MMRC  dyspnea  scale  and  evaluated  after  PR.  There
as  an  improvement  in  6-minute  walking  test  and  SGRQ
nly  in  the  patients  with  dyspnea  score:  grade  1/2  and
rade  3/4  while  the  improvement  in  grade  5  patients  was
ery  limited.  The  authors  suggested  that  baseline  state  is
 poor  predictor  of  response  to  rehabilitation.45 Despite
hat,  in  our  study,  baseline  DlCO levels  were  good  pre-
ictors  for  better  PR  outcome.  Although  the  MMRC  and
ORG  scores  were  higher  in  patients  with  severe  diffusion
efect,  these  scores  signiﬁcantly  decreased  after  PR.  Also
alking  distance  within  group  2  (not  statistically  signiﬁ-
ant  between  groups)  was  increased  signiﬁcantly  after  PR.
hen  the  two  groups  were  compared  in  terms  of  MMRC  and
ORG  dyspnea  score  changes,  the  augmentation  of  MMRC
nd  BORG  score  was  signiﬁcantly  higher  in  patients  with
evere  diffusion  defect.  Additionally,  anxiety  score  was  the
nly  parameter  decreased  in  patients  with  moderate  diffu-
ion  defect  whereas  both  anxiety  score  and  depression  score
ere  decreased  in  patients  with  severe  diffusion  defect.
onclusion
e  concluded  that  pulmonary  rehabilitation  improves  oxy-
enation,  severity  of  dyspnea,  exercise  capacity  and  quality
f  life  in  patents  with  COPD  independent  of  carbon  monoxide
iffusion  capacity  levels.  Furthermore  pulmonary  rehabilita-
ion  may  improve  DlCO and  FEV1  values  in  COPD  patients  with
evere  diffusion  defect.  However  long-term  follow  up  stud-
es  are  needed  to  have  the  best  results  from  rehabilitation
rograms.
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